Telbivudine Renoprotective Effect in Patients With HBV-related Liver Cirrhosis
Clinical trial NCT01693679 · UNKNOWN
Trial details
- NCT number
- NCT01693679
- Sponsor
- Shao-quan Zhang
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2014-04-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.